Form 4 filed by Daewoong Co., Ltd
Daewoong Co., Ltd filed this Form 4 on AEON (AEON Biopharma, Inc.) with 3 transaction rows and 3 holding rows, accepted by EDGAR 2026-11-10 16:35:47 UTC.
- Accession
- 0001213900-26-117865
- Filer
- CIK 1985493
- Filed
- 2026-11-10
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: AEON · AEON Biopharma, Inc. (CIK 1837607)
- Daewoong Co., Ltd 10% owner
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Class A Common Stock, $0.0001 par value per share | 2026-10-30 | X exercised | +11,236,631 | $0.0001 | 23,188,345 | I By Daewoong Pharmaceutical Co., Ltd. |
| Class A Common Stock, $0.0001 par value per share | 2026-10-30 | J other | -3,822 | $0.294 | 23,184,523 | I By Daewoong Pharmaceutical Co., Ltd. |
| Class A Common Stock, $0.0001 par value per share holding | 58,023 | D | ||||
| Pre-Funded Warrant (right to buy) derivative | 2026-10-30 | X exercised | -11,236,631 | $0 | 0 | I By Daewoong Pharmaceutical Co., Ltd. |
| Common Stock Warrant (right to buy) derivativeholding | 8,000,000 | I By Daewoong Pharmaceutical Co., Ltd. | ||||
| Senior Secured Convertible Note derivativeholding | I By Daewoong Pharmaceutical Co., Ltd. |